Scheduling software company Forgent Networks has sued Microsoft in a Texas district court, alleging infringement of a patent that it says covers the compression, manipulation and transmission of JPEG images.
JPEG is short for the "Joint Photographic Experts Group," which comprises experts nominated by national standards bodies and major companies to work to produce standards for continuous tone image coding.The best-known standard from JPEG is IS 10918-1, which is the first of a multi-part set of standards for still image compression. A basic version of the many features of this standard is what most people think of as JPEG – and this is where Forgent is claiming a monopoly right.The patent is owned by Compression Labs, which applied for it in 1986, but never pursued royalties. Forgent subsequently acquired Compression Labs and startled the computer industry in 2002 when it announced that it would be seeking royalties relating to digital image compression.The suit, filed in the US District Court of the Eastern District of Texas, follows a pre-emptive strike by Microsoft, which filed suit on 15th April in a California Court, asking the court to declare that it did not infringe on Forgent's patent, and that the patent itself was invalid and unenforceable."It's unfortunate that, despite Microsoft's recent inquiries about licensing the patent, they chose to file a lawsuit, leaving us no alternative but to assert infringement claims against it," said Richard Snyder, chairman and CEO of Forgent.Forgent has been down this road before, suing 44 other companies for infringement of the JPEG patent. An action last year targeted 31 companies including Apple, IBM, Adobe, Gateway and Xerox.To date, says Forgent, it has generated more than $100 million from licensing the patent.Microsoft has not yet commented on the suit.
Parties seeking to fund litigation or international arbitration in an EU member state through a third-party funder need to be aware of the principles set out by the European Law Institute (ELI), particularly the guidance on transparency, funders’ fees, control of the funded proceedings and capital adequacy.
Upcoming changes to existing competition rules and the introduction of new rules will substantially strengthen and expand the UK Competition and Markets Authority’s (CMA) investigatory and enforcement powers resulting in higher stakes for businesses that do not comply, an expert has said.
A recent study on the population-health impact of new drugs demonstrates a disconnected economist-driven approach to the benefits that such drugs provide, experts have said.
We use cookies that are essential for our site to work. To improve our site, we would like to use additional cookies to help us understand how visitors use it, measure traffic to our site from social media platforms and to personalise your experience. Some of the cookies that we use are provided by third parties. To accept all cookies click ‘accept all’. To reject all optional cookies click ‘reject all’. To choose which optional cookies to allow click ‘cookie settings’. This tool uses a cookie to remember your choices.
Please visit our cookie policy for more information.
We are processing your request. \n Thank you for your patience.An error occurred. This could be due to inactivity on the page - please try again.